What are the responsibilities and job description for the Chief Medical Officer (CMO) | Immuno-Oncology position at CSG Talent?
Chief Medical Officer (CMO) | Immuno-Oncology | Cambridge, MA
Location : Cambridge, MA (Hybrid / Flexible)
Salary : Competitive base bonus equity
Sector : Biotechnology | Clinical Development | Immuno-Oncology
Job Type : Full-time | Permanent
Job Description
A high-growth VC-backed biotech specializing in Immuno-Oncology is seeking a Chief Medical Officer (CMO) to lead clinical and regulatory strategy , driving the development of cutting-edge IO therapies from IND through regulatory approval .
This is a unique opportunity for a clinical development leader to shape the success of a pioneering biotech at the forefront of immune-based cancer therapeutics .
Key Responsibilities
- Define and oversee the clinical development strategy for a first-in-class IO pipeline .
- Lead IND, CTA, and regulatory filings , engaging with FDA, EMA, and global health authorities .
- Direct Phase I-III clinical trials , ensuring scientific and operational excellence.
- Collaborate with R&D and translational medicine teams to optimize biomarker-driven trial design.
- Represent the company at scientific conferences, investor meetings, and key industry events .
- Partner with BD and Commercial teams on strategic partnerships and future market planning.
Candidate Profile
Why Apply?
Lead the development of cutting-edge Immuno-Oncology therapeutics.
Equity participation in a high-potential biotech with strong investor backing.
Strategic Impact - Drive the success of a transformative IO pipeline .
Desired Skills and Experience
MD (or MD / PhD) with 15 years of experience in clinical development.
Extensive experience in Immuno-Oncology drug development, including checkpoint inhibitors, cell therapies, or novel IO approaches.
Proven track record of advancing oncology assets from early-phase trials through regulatory approval.
Strong experience in regulatory interactions (FDA, EMA) and global trial execution.
Ability to thrive in a VC-backed, high-growth biotech environment.